VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomasin vivo
- 1 January 1999
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 13 (1) , 181-189
- https://doi.org/10.1096/fasebj.13.1.181
Abstract
A novel member of the tumor necrosis factor (TNF) family has been identified from the human umbilical vein endothelial cell cDNA library, named vascular endothelial growth inhibitor (VEGI). The VEG...Keywords
This publication has 19 references indexed in Scilit:
- LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer.Journal of Clinical Investigation, 1998
- Fas and other cell death signaling pathwaysSeminars in Immunology, 1997
- Portrait of an executioner: the molecular mechanism of Fas/APO-1-induced apoptosisSeminars in Immunology, 1997
- Antitumor effect of locally produced CD95 ligandNature Medicine, 1997
- Cytokine Gene Therapy of Cancer Using Interleukin‐12: Murine and Clinical TrialsAnnals of the New York Academy of Sciences, 1996
- Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine FamilyJournal of Biological Chemistry, 1996
- Recent advances in tumor necrosis factor and CD40 signalingCurrent Opinion in Genetics & Development, 1996
- The Potential Applications of Gene Transfer in the Treatment of Patients with Cancer: A Concise ReviewCancer Investigation, 1996
- Identification and characterization of a new member of the TNF family that induces apoptosisImmunity, 1995
- Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer.The Journal of Experimental Medicine, 1991